Quantitative expression analyses of candidates for alternative anion conductance in cystic fibrosis mouse models  Josephine Braun, Lars Mundhenk, Friederike.

Slides:



Advertisements
Similar presentations
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Advertisements

Serum matrix metalloproteinases in adult CF patients: Relation to pulmonary exacerbation  Martin Roderfeld, Timo Rath, Richard Schulz, Werner Seeger,
Use of high-dose ibuprofen in a pediatric cystic fibrosis center
Zachary M. Sellers, Lori McGlocklin, Andrea Brasch 
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
H. Grasemann, E. Tullis, F. Ratjen  Journal of Cystic Fibrosis 
Katarine Egressy, Michaelene Jansen, Keith C. Meyer 
Megan R. Nelson, Craig R. Adamski, Audrey Tluczek 
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Nadav Traeger, Qiuhu Shi, Allen J. Dozor  Journal of Cystic Fibrosis 
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Laura Viviani, Baroukh M. Assael, Eitan Kerem 
Regional ventilation in cystic fibrosis measured by electrical impedance tomography  Zhanqi Zhao, Rainald Fischer, Inéz Frerichs, Ullrich Müller-Lisse,
Statistical limitations of percent ideal body weight as measure for nutritional failure in patients with cystic fibrosis  T.O. Hirche, H. Hirche, S. Jungblut,
Cirrhosis and other liver disease in cystic fibrosis
Katelyn Krivchenia, Don Hayes, Joseph D. Tobias, Dmitry Tumin 
John Widger, Sarath Ranganathan, Philip J. Robinson 
The ease of breathing test tracks clinical changes in cystic fibrosis
Amanda L. Brennan, Khin M. Gyi, David M
Expression of the inflammatory regulator A20 correlates with lung function in patients with cystic fibrosis  Catriona Kelly, Mark T. Williams, J. Stuart.
Adherence to nebulised therapies in adolescents with cystic fibrosis is best on week- days during school term-time  Rosemary Ball, Kevin W. Southern, Pamela.
Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study  Christine Rønne.
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Vitamin A and lung function in CF
Efficacy of high dose phylloquinone in correcting vitamin K deficiency in cystic fibrosis  Donna Drury, Vijay Laxmi Grey, Guylaine Ferland, Caren Gundberg,
Pulmonary nocardiosis in cystic fibrosis
A.H. Gifford  Journal of Cystic Fibrosis 
M. Wouthuyzen-Bakker, F.A.J.A. Bodewes, H.J. Verkade 
Shaoyan Zhang, Neel K. Ranganath, Daniel Skinner, David M
Tregony Simoneau, Gregory S. Sawicki, Carly E. Milliren, Henry A
M. Al-Aloul, M. Jackson, G. Bell, M. Ledson, M. Walshaw 
Physiologic endpoints for clinical studies for cystic fibrosis
Antonia V. Bennett, Donald L. Patrick, James F. Lymp, Todd C
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Colon Cancer in Cystic Fibrosis patients: Is this a growing problem?
Sally H. Pattison, Geraint B. Rogers, Martin Crockard, J
Cytokine gene polymorphisms and severity of CF lung disease
Nasal polyposis in lung transplant recipients with cystic fibrosis
Narelle S. Cox, Jennifer Follett, Karen O. McKay 
Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis  Geraint B. Rogers, Lucas R. Hoffman,
Theresa A. Laguna, Cynthia B. Williams, Kyle R
Nutritional decline in cystic fibrosis related diabetes: The effect of intensive nutritional intervention  H. White, K. Pollard, C. Etherington, I. Clifton,
Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients  Valerie Waters, Eshetu G. Atenafu, Annie.
Gender differences in treatment adherence among youth with cystic fibrosis: Development of a new questionnaire  Joän M. Patterson, Melanie Wall, Jerica.
Respiratory pathogens mediate the association between lung function and temperature in cystic fibrosis  Joseph M. Collaco, Karen S. Raraigh, Lawrence.
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
A new method of sweat testing: the CF Quantum®sweat test
A. Sapet, A. C. Normand, M. Oudyi, N. Stremler- Le Bel, R. Piarroux, J
V. Thompson, N. Mayer-Hamblett, M. Kloster, D. Bilton, P.A. Flume 
Determining presence of lung disease in young children with cystic fibrosis: Lung clearance index, oxygen saturation and cough frequency  E.M. Bakker,
Stability of interleukin 8 and neutrophil elastase in bronchoalveolar lavage fluid following long-term storage  Luke J. Berry, Barbara Sheil, Luke Garratt,
Modification of the salivary secretion assay in F508del mice — The murine equivalent of the human sweat test  Karoline Droebner, Peter Sandner  Journal.
Soluble inflammation markers in nasal lavage from CF patients and healthy controls  Natalie Beiersdorf, Matthias Schien, Julia Hentschel, Wolfgang Pfister,
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
Impact of IVS8-(TG)m(T)n on IRT and sweat chloride levels in newborns identified by California CF newborn screening  Steven Keiles, Ruth Koepke, Richard.
Michael W. Konstan, David J. Pasta, Jeffrey S. Wagener, Donald R
Serum-surfactant SP-D correlates inversely to lung function in cystic fibrosis  Hanne Vebert Olesen, Uffe Holmskov, Peter Oluf Schiøtz, Grith Lykke Sørensen 
The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation  C. Etherington,
Gut dysbiosis in cystic fibrosis
CFTR modulators and pregnancy: Our work has only just begun
‘Peeling paint’ dermatitis as a presenting sign of cystic fibrosis
Sophie Yammine, Florian Singer, Per Gustafsson, Philipp Latzin 
Airway inflammation in mild cystic fibrosis
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub 
Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern? 
Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L
Absence of a gender gap in survival
Presentation transcript:

Quantitative expression analyses of candidates for alternative anion conductance in cystic fibrosis mouse models  Josephine Braun, Lars Mundhenk, Friederike Range, Achim D. Gruber  Journal of Cystic Fibrosis  Volume 9, Issue 5, Pages 351-364 (September 2010) DOI: 10.1016/j.jcf.2010.06.003 Copyright © 2010 European Cystic Fibrosis Society Terms and Conditions

Fig. 1 Comparison of relative expression levels between the wild type strains. For each organ analyzed – (A) stomach, duodenum, jejunum, caecum, colon, and (B) pancreas, liver, lung and kidney – the relative mRNA copy numbers of the genes of interest (GOI) for both the BALB/c (black columns) and the NMRI (grey columns) mice are plotted. Among the 15 candidate genes analyzed, mCLCA4 had strongest overall expression, followed by mCLC-3B, mTTYH3, mTMEM16A and mCLCA3. mCLCA5, mBEST1 and mCLCA1 had lowest to negligible expression levels. In the box plots, outliers are marked by circles, extreme values by asterisks. An outlier has a value of more than 1.5 quartile spaces beyond the middle 50%. An extreme value is more than 3 quartile spaces beyond. A horizontal bracket with a hash marks a statistically significant difference between the BALB/c and NMRI wild type strain. The y-axis is scaled in log to the base of 10. n=5 mice per group. Journal of Cystic Fibrosis 2010 9, 351-364DOI: (10.1016/j.jcf.2010.06.003) Copyright © 2010 European Cystic Fibrosis Society Terms and Conditions

Fig. 1 Comparison of relative expression levels between the wild type strains. For each organ analyzed – (A) stomach, duodenum, jejunum, caecum, colon, and (B) pancreas, liver, lung and kidney – the relative mRNA copy numbers of the genes of interest (GOI) for both the BALB/c (black columns) and the NMRI (grey columns) mice are plotted. Among the 15 candidate genes analyzed, mCLCA4 had strongest overall expression, followed by mCLC-3B, mTTYH3, mTMEM16A and mCLCA3. mCLCA5, mBEST1 and mCLCA1 had lowest to negligible expression levels. In the box plots, outliers are marked by circles, extreme values by asterisks. An outlier has a value of more than 1.5 quartile spaces beyond the middle 50%. An extreme value is more than 3 quartile spaces beyond. A horizontal bracket with a hash marks a statistically significant difference between the BALB/c and NMRI wild type strain. The y-axis is scaled in log to the base of 10. n=5 mice per group. Journal of Cystic Fibrosis 2010 9, 351-364DOI: (10.1016/j.jcf.2010.06.003) Copyright © 2010 European Cystic Fibrosis Society Terms and Conditions

Fig. 2 Comparison of relative expression levels between the wild type and cftrTgH(neoim)Hgu mice on the BALB/c background. A) The relative mRNA copy numbers of mBEST1, mBEST2, mCLC-3B, mCLC-4 and mTTYH3 are plotted for both the wild type (black columns) and CF (grey columns) tissues of the BALB/c mice. B) The relative mRNA copy numbers of mTMEM16A, mTMEM16F, mTMEM16K and SLC26A9 are plotted for both the wild type (black columns) and CF (grey columns) tissues of the BALB/c mice. C) The relative mRNA copy numbers of the CLCA family members mCLCA1 to -6 are plotted for both the wild type (black columns) and CF (grey columns) tissues of the BALB/c mice. In all the box plots, outliers are marked by circles, extreme values by asterisks. An outlier has a value of more than 1.5 quartile spaces beyond the middle 50%. An extreme value is more than 3 quartile spaces beyond. A horizontal bracket with a hash marks a statistically significant difference between the wild type and CF groups. The y-axis is scaled in log to the base of 10. n=5 mice per group. Journal of Cystic Fibrosis 2010 9, 351-364DOI: (10.1016/j.jcf.2010.06.003) Copyright © 2010 European Cystic Fibrosis Society Terms and Conditions

Fig. 2 Comparison of relative expression levels between the wild type and cftrTgH(neoim)Hgu mice on the BALB/c background. A) The relative mRNA copy numbers of mBEST1, mBEST2, mCLC-3B, mCLC-4 and mTTYH3 are plotted for both the wild type (black columns) and CF (grey columns) tissues of the BALB/c mice. B) The relative mRNA copy numbers of mTMEM16A, mTMEM16F, mTMEM16K and SLC26A9 are plotted for both the wild type (black columns) and CF (grey columns) tissues of the BALB/c mice. C) The relative mRNA copy numbers of the CLCA family members mCLCA1 to -6 are plotted for both the wild type (black columns) and CF (grey columns) tissues of the BALB/c mice. In all the box plots, outliers are marked by circles, extreme values by asterisks. An outlier has a value of more than 1.5 quartile spaces beyond the middle 50%. An extreme value is more than 3 quartile spaces beyond. A horizontal bracket with a hash marks a statistically significant difference between the wild type and CF groups. The y-axis is scaled in log to the base of 10. n=5 mice per group. Journal of Cystic Fibrosis 2010 9, 351-364DOI: (10.1016/j.jcf.2010.06.003) Copyright © 2010 European Cystic Fibrosis Society Terms and Conditions

Fig. 2 Comparison of relative expression levels between the wild type and cftrTgH(neoim)Hgu mice on the BALB/c background. A) The relative mRNA copy numbers of mBEST1, mBEST2, mCLC-3B, mCLC-4 and mTTYH3 are plotted for both the wild type (black columns) and CF (grey columns) tissues of the BALB/c mice. B) The relative mRNA copy numbers of mTMEM16A, mTMEM16F, mTMEM16K and SLC26A9 are plotted for both the wild type (black columns) and CF (grey columns) tissues of the BALB/c mice. C) The relative mRNA copy numbers of the CLCA family members mCLCA1 to -6 are plotted for both the wild type (black columns) and CF (grey columns) tissues of the BALB/c mice. In all the box plots, outliers are marked by circles, extreme values by asterisks. An outlier has a value of more than 1.5 quartile spaces beyond the middle 50%. An extreme value is more than 3 quartile spaces beyond. A horizontal bracket with a hash marks a statistically significant difference between the wild type and CF groups. The y-axis is scaled in log to the base of 10. n=5 mice per group. Journal of Cystic Fibrosis 2010 9, 351-364DOI: (10.1016/j.jcf.2010.06.003) Copyright © 2010 European Cystic Fibrosis Society Terms and Conditions

Fig. 3 Comparison of relative expression levels between the wild type and cftrtm1Cam mice on the NMRI background. A) The relative mRNA copy numbers of mBEST1, mBEST2, mCLC-3B, mCLC-4 and mTTYH3 are plotted for both the wild type (black columns) and CF (grey columns) tissues of the NMRI mice. B) The relative mRNA copy numbers of mTMEM16A, mTMEM16F, mTMEM16K and SLC26A9 are plotted for both the wild type (black columns) and CF (grey columns) tissues of the NMRI mice. C) The relative mRNA copy numbers of the CLCA family members mCLCA1 to -6 are plotted for both the wild type (black columns) and CF (grey columns) tissues of the NMRI mice. In all the box plots, outliers are marked by circles, extreme values by asterisks. An outlier has a value of more than 1.5 quartile spaces beyond the middle 50%. An extreme value is more than 3 quartile spaces beyond. A horizontal bracket with a hash marks a statistically significant difference between the wild type and CF groups. The y-axis is scaled in log to the base of 10. n=5 mice per group. Journal of Cystic Fibrosis 2010 9, 351-364DOI: (10.1016/j.jcf.2010.06.003) Copyright © 2010 European Cystic Fibrosis Society Terms and Conditions

Fig. 3 Comparison of relative expression levels between the wild type and cftrtm1Cam mice on the NMRI background. A) The relative mRNA copy numbers of mBEST1, mBEST2, mCLC-3B, mCLC-4 and mTTYH3 are plotted for both the wild type (black columns) and CF (grey columns) tissues of the NMRI mice. B) The relative mRNA copy numbers of mTMEM16A, mTMEM16F, mTMEM16K and SLC26A9 are plotted for both the wild type (black columns) and CF (grey columns) tissues of the NMRI mice. C) The relative mRNA copy numbers of the CLCA family members mCLCA1 to -6 are plotted for both the wild type (black columns) and CF (grey columns) tissues of the NMRI mice. In all the box plots, outliers are marked by circles, extreme values by asterisks. An outlier has a value of more than 1.5 quartile spaces beyond the middle 50%. An extreme value is more than 3 quartile spaces beyond. A horizontal bracket with a hash marks a statistically significant difference between the wild type and CF groups. The y-axis is scaled in log to the base of 10. n=5 mice per group. Journal of Cystic Fibrosis 2010 9, 351-364DOI: (10.1016/j.jcf.2010.06.003) Copyright © 2010 European Cystic Fibrosis Society Terms and Conditions

Fig. 3 Comparison of relative expression levels between the wild type and cftrtm1Cam mice on the NMRI background. A) The relative mRNA copy numbers of mBEST1, mBEST2, mCLC-3B, mCLC-4 and mTTYH3 are plotted for both the wild type (black columns) and CF (grey columns) tissues of the NMRI mice. B) The relative mRNA copy numbers of mTMEM16A, mTMEM16F, mTMEM16K and SLC26A9 are plotted for both the wild type (black columns) and CF (grey columns) tissues of the NMRI mice. C) The relative mRNA copy numbers of the CLCA family members mCLCA1 to -6 are plotted for both the wild type (black columns) and CF (grey columns) tissues of the NMRI mice. In all the box plots, outliers are marked by circles, extreme values by asterisks. An outlier has a value of more than 1.5 quartile spaces beyond the middle 50%. An extreme value is more than 3 quartile spaces beyond. A horizontal bracket with a hash marks a statistically significant difference between the wild type and CF groups. The y-axis is scaled in log to the base of 10. n=5 mice per group. Journal of Cystic Fibrosis 2010 9, 351-364DOI: (10.1016/j.jcf.2010.06.003) Copyright © 2010 European Cystic Fibrosis Society Terms and Conditions